Venlafaxine involves nitric oxide modulatory mechanism in experimental model of chronic behavior despair in mice

Brain Research
Anil KumarPuneet Kumar

Abstract

Present study has been designed to elucidate the nitric oxide modulatory mechanism of venlafaxine in experimental model of chronic behavior despair in mice. Animals (male albino laca mice) were forced to swim daily for 6 min test session for 7 days and immobility period of each animal was measured on every alternate days. Six minutes forced swimming test session for 7 days caused anxiety-like behavior (as assessed by mirror chamber and plus maze tests) and impairment in locomotor activity followed by oxidative damage (increased lipid peroxidation, nitrite concentration, depleted reduced glutathione and catalase activity) as compared to naïve animals. Seven days venlafaxine (5 and 10 mg/kg) treatment significantly caused anti-anxiety-like effect, improved locomotor activity and attenuated oxidative damage (reduced lipid peroxidation, nitrite concentration and caused restoration of reduce glutathione and catalase activity) as compared to control. Caffeine (10 mg/kg) pretreatment with venlfaxine (5 mg/kg) did not produce any significant effect on locomotor activity, immobility period and oxidative damage as compared to their effect per se. Further, L-NAME (5 mg/kg) and methylene blue (10 mg/kg) pretreatment with sub effective dose...Continue Reading

References

Mar 1, 1975·Journal of Human Stress·J W Mason
Jan 1, 1991·Reviews of Infectious Diseases·A L Komaroff, D Buchwald
Jun 1, 1966·The Biochemical Journal·E D Wills
Oct 1, 1982·Analytical Biochemistry·L C GreenS R Tannenbaum
Jan 1, 1994·Archives of Biochemistry and Biophysics·R RadiR Telleri
Jan 1, 1996·The American Journal of Medicine·A L KomaroffR T Guerriero
Jul 19, 1997·BMJ : British Medical Journal·M SharpeP J Cowen
Jul 22, 1998·Journal of Neuroscience Research·X M LiA A Boulton
Apr 13, 2000·Brain Research. Brain Research Reviews·A Contestabile
Jun 6, 2000·Pharmacology, Biochemistry, and Behavior·G Tanda, S R Goldberg
Jan 11, 2000·The American Journal of Medicine·A L Komaroff
Nov 28, 2001·Psychological Medicine·A J ParkerA J Cleare
Mar 6, 2002·British Journal of Pharmacology·Juan V Esplugues
Jul 31, 2002·The Journal of Cell Biology·Sean P CreganRuth S Slack
Mar 18, 2003·Journal of Medicinal Food·Amanpreet SinghShrinivas K Kulkarni
May 1, 1959·Archives of Biochemistry and Biophysics·G L ELLMAN
Sep 27, 2003·Clinical Therapeutics·Mary A GutierrezJanet Y Aiso
Feb 6, 2004·Neuroimmunomodulation·Dimitris A PapanicolaouAnthony Kales
Feb 6, 2004·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·R L TorresA A Belló
Apr 13, 2004·International Clinical Psychopharmacology·M Erkan OzcanOmer Akyol
May 28, 2004·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Andrew HarkinJohn P Kelly
Aug 10, 2004·The Journal of Experimental Biology·David S WarnerInes Batinić-Haberle
Mar 29, 2006·Proceedings of the National Academy of Sciences of the United States of America·Leila M SoraviaDominique J-F de Quervain
Sep 19, 2006·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·L D Devanur, J R Kerr
Dec 19, 2006·Archives of Medical Research·Ross S RichardsHerbert Jelinek
Dec 22, 2006·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Nashat AbumariaGabriele Flügge
Mar 24, 2007·Progress in Neuro-psychopharmacology & Biological Psychiatry·Ashish Dhir, S K Kulkarni
Mar 14, 2008·Pharmacology, Biochemistry, and Behavior·Ashish Dhir, S K Kulkarni
Nov 22, 2008·Progress in Neuro-psychopharmacology & Biological Psychiatry·Puneet Kumar, Anil Kumar

❮ Previous
Next ❯

Citations

Dec 15, 2010·Lipids in Health and Disease·Whitney P Bowe, Alan C Logan
Jun 21, 2014·Pharmacological Reports : PR·Mamta Sachdeva DhingraManinder Karan
Jan 19, 2011·Journal of Proteomics·Angelo D'AlessandroLello Zolla
Dec 19, 2012·Psychiatry Research·Cecilia P ChungRonald M Salomon
Aug 11, 2012·Pharmacology, Biochemistry, and Behavior·Anil KumarJitendriya Mishra
Jun 4, 2011·European Journal of Pharmacology·Anurag MaheshwariPrasad Thakurdesai
Jul 4, 2015·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Miriam A VogtDragos Inta
Dec 27, 2012·Progress in Neuro-psychopharmacology & Biological Psychiatry·W N Marsden
Jun 12, 2016·Neurochemistry International·Danielle Santana-CoelhoMaria Elena Crespo-López
Apr 9, 2014·Behavioural Pharmacology·Vinicius A Hiroaki-SatoSâmia R L Joca
Oct 21, 2019·Metabolic Brain Disease·Mohammad Taghi MansouriSoheila Alboghobeish

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.